Patel Snehal (CIK 1806920) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-15). Recent activity: Buy GLSI (1,800 shares), Buy GLSI (2,900 shares), Buy GLSI (4,300 shares), Buy GLSI (2,900 shares), Buy GLSI (4,100 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-15 | Greenwich LifeSciences, Inc. (GLSI) | CEO and CFO | Buy | 1,800 | $53,694 |
| 2026-01-14 | Greenwich LifeSciences, Inc. (GLSI) | CEO and CFO | Buy | 2,900 | $79,866 |
| 2026-01-05 | Greenwich LifeSciences, Inc. (GLSI) | CEO and CFO | Buy | 4,300 | $91,848 |
| 2026-01-02 | Greenwich LifeSciences, Inc. (GLSI) | CEO and CFO | Buy | 2,900 | $63,017 |
| 2025-12-19 | Greenwich LifeSciences, Inc. (GLSI) | CEO and CFO | Buy | 4,100 | $51,742 |
| 2025-11-28 | Greenwich LifeSciences, Inc. (GLSI) | CEO and CFO | Buy | 4,600 | $38,502 |
| 2025-11-12 | Greenwich LifeSciences, Inc. (GLSI) | CEO and CFO | Buy | 10,600 | $89,358 |
| 2025-11-04 | Greenwich LifeSciences, Inc. (GLSI) | CEO and CFO | Buy | 2,300 | $21,298 |
| 2025-04-29 | Greenwich LifeSciences, Inc. (GLSI) | CEO and CFO | Buy | 3,600 | $35,568 |
| 2025-04-22 | Greenwich LifeSciences, Inc. (GLSI) | CEO and CFO | Buy | 5,400 | $48,492 |
| 2025-04-08 | Greenwich LifeSciences, Inc. (GLSI) | CEO and CFO | Buy | 3,600 | $32,760 |
| 2025-04-07 | Greenwich LifeSciences, Inc. (GLSI) | CEO and CFO | Buy | 5,500 | $48,015 |
Source: SEC Form 4 filings · as of 2026-01-15